| Literature DB >> 24334408 |
F H Nociti1, B L Foster, A B Tran, D Dunn, R B Presland, L Wang, N Bhattacharyya, M T Collins, M J Somerman.
Abstract
Calcium and phosphorus homeostasis is achieved by interplay among hormones, including 1,25(OH)2D3 (1,25D), parathyroid hormone, and fibroblast growth factor 23 (FGF23), and their interactions with other proteins. For example, mutations in dentin matrix protein 1 (DMP-1) result in increased FGF23 and hypophosphatemic rickets. 1,25D is reported to modulate FGF23; thus, we hypothesized that 1,25D may be involved in modulating DMP-1 in an intermediary step. Murine cementoblasts (OCCM-30) and osteocyte-like cells (MLO-Y4 and MLO-A5), known to express DMP-1, were used to analyze effects of 1,25D on DMP-1 expression in vitro. DMP-1 mRNA levels decreased by 50% (p < .05) in the presence of 1,25D in all cell types, while use of a vitamin D receptor (VDR) agonist (EB1089) and antagonist (23S,25S)-DLAM-2P confirmed that VDR pathway activation was required for this response. Further analysis showed that histone deacetylase recruitment was necessary, but neither protein kinase A nor C pathways were required. In conclusion, our results support the hypothesis that 1,25D regulates DMP-1 expression through a VDR-dependent mechanism, possibly contributing to local changes in bone/tooth mineral homeostasis.Entities:
Keywords: SIBLING family; Vitamin D receptor; fibroblast growth factor 23; osteogenesis; phosphate homeostasis; phosphate regulating endopeptidase homolog
Mesh:
Substances:
Year: 2013 PMID: 24334408 PMCID: PMC6728571 DOI: 10.1177/0022034513516344
Source DB: PubMed Journal: J Dent Res ISSN: 0022-0345 Impact factor: 6.116